Searched for
ANTACID DIGENE GEL
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%With the IT sector continuing to be the pain point for the market, it is essential to differentiate between what is leading to the fall in ...- These large- and mid-cap stocks can have an upside potential of more than 24% in 1 year, according to analystsWith the bulls making yet another comeback bid, the question on the street is familiar: Are valuations still high, or has the recent correc...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 25%The markets have been in a corrective phase for some time. When corrections are sparked by global events, they may be short time-wise, but ...
- Pharma stocks: Time to change the prescription? 13 pharma stocks with an upside potential of up to 39%Close to three decades back, when Indian pharma firms began to move into the US market, they faced many challenges. And the fact is that th...
- Abbott India warns of laxatives shortage in tussle with Goa regulatorAbbott Laboratories' Indian unit has warned of potential supply shortages of two popular laxative syrups, Cremaffin and Duphalac, after pro...
- Implementing corrective actions at Goa unit; stopped Digene production at the facility: AbbottThe drug regulatory body also advised doctors and healthcare professionals to carefully prescribe and educate their patients to discontinue...
- Digene Gel recall: Goa state warns Abbott India on antacid license suspensionThe U.S. based drugmaker is locked in a tussle with drug regulators in the tourist state of Goa in western India after the company, startin...
- DCGI asks states to keep vigil on sale of falsified versions of 2 drugs following WHO alertsThe Drugs Controller General of India (DCGI) has issued an advisory to keep a strict watch on the sale and distribution of falsified versio...
- DCGI issues advisory as US-based Abbott recalls batches of Digene gelAbbott India Limited, through a letter dated August 18, intimated to DCGI regarding voluntary product recall of all batches of Digene Gel o...
- DCGI issues advisory against Digene Gel; raises safety concerns after Abbott's voluntary recallThe Drugs Controller General of India has advised patients and healthcare professionals to stop using Digene gel, a popular antacid, due to...
Load More
